Literature DB >> 11880523

Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum.

Marie-Louise Kemel1, Sylvie Pérez, Gérard Godeheu, Philippe Soubrié, Jacques Glowinski.   

Abstract

Using a microsuperfusion method in vitro, the effects of the NK1, NK2, and NK3 tachykinin receptor antagonists SR140333, SR48968, and SR142801, respectively, on the NMDA-evoked release of [3H]-acetylcholine were investigated after both acute and chronic suppression of dopamine transmission in striosomes and matrix of the rat striatum. NMDA (1 mm) alone or with D-serine (10 microm) in the presence of alpha-methyl-p-tyrosine (100 microm) markedly enhanced the release of [3H]-acetylcholine through a dopamine-independent inhibitory process. In both conditions, as well as after chronic 6-OHDA-induced denervation of striatal dopaminergic fibers, SR140333, SR48968, or SR142801 (0.1 microm each) reduced the NMDA-evoked release of [3H]-acetylcholine in the matrix but not in striosome-enriched areas. These responses were selectively abolished by coapplication with NMDA of the respective tachykinin agonists, septide, [Lys5,MeLeu9,Nle10]NKA(4-10), or senktide. Distinct mechanisms are involved in the effects of the tachykinin antagonists because the inhibitory response of SR140333 was additive with that of either SR48968 or SR142801. In addition, the SR140333-evoked response remained unchanged, whereas those of SR48968 and SR142801 were abolished in the presence of N(G)-monomethyl-l-arginine (nitric oxide synthase inhibitor). Therefore, in the matrix but not in striosomes, the acute or chronic suppression of dopamine transmission unmasked the facilitatory effects of endogenously released substance P, neurokinin A, and neurokinin B on the NMDA-evoked release of [3H]-acetylcholine. Whereas substance P and neurokinin A are colocalized in same efferent neurons, their responses involve distinct circuits because the substance P response seems to be mediated by NK1 receptors located on cholinergic interneurons, while those of neurokinin A and neurokinin B are nitric oxide-dependent.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880523      PMCID: PMC6758863     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

1.  Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin.

Authors:  M J Besson; A M Graybiel; B Quinn
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

2.  Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum.

Authors:  M Herkenham; C B Pert
Journal:  Nature       Date:  1981-06-04       Impact factor: 49.962

3.  SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor.

Authors:  X Emonds-Alt; D Bichon; J P Ducoux; M Heaulme; B Miloux; M Poncelet; V Proietto; D Van Broeck; P Vilain; G Neliat
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

4.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.

Authors:  C R Gerfen; T M Engber; L C Mahan; Z Susel; T N Chase; F J Monsma; D R Sibley
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

5.  Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: an in vivo microdialysis study.

Authors:  R Steinberg; D Rodier; J Souiclhac; I Bougault; X Emonds-Alt; P Soubrié; G Le Fur
Journal:  J Neurochem       Date:  1995-12       Impact factor: 5.372

6.  Spatial organization of patch and matrix compartments in the rat striatum.

Authors:  M Desban; M L Kemel; J Glowinski; C Gauchy
Journal:  Neuroscience       Date:  1993-12       Impact factor: 3.590

7.  Effect of substance P on acetylcholine and dopamine release in the rat striatum: a microdialysis study.

Authors:  R G Guzman; K M Kendrick; P C Emson
Journal:  Brain Res       Date:  1993-09-17       Impact factor: 3.252

8.  Distinct modifications by neurokinin1 (SR140333) and neurokinin2 (SR48968) tachykinin receptor antagonists of the N-methyl-D-aspartate-evoked release of acetylcholine in striosomes and matrix of the rat striatum.

Authors:  F Blanchet; C Gauchy; S Perez; P Soubrié; J Glowinski; M L Kemel
Journal:  Neuroscience       Date:  1998-08       Impact factor: 3.590

9.  In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist.

Authors:  X Emonds-Alt; J D Doutremepuich; M Heaulme; G Neliat; V Santucci; R Steinberg; P Vilain; D Bichon; J P Ducoux; V Proietto
Journal:  Eur J Pharmacol       Date:  1993-12-21       Impact factor: 4.432

10.  The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.

Authors:  J J Anderson; S Randall; T N Chase
Journal:  J Pharmacol Exp Ther       Date:  1995-08       Impact factor: 4.030

View more
  3 in total

1.  Possible mechanisms of the involvement of dopaminergic cells and cholinergic interneurons in the striatum in the conditioned-reflex selection of motor activity.

Authors:  I G Sil'kis
Journal:  Neurosci Behav Physiol       Date:  2006-02

Review 2.  Tachykinins and excitotoxicity in cerebellar granule cells.

Authors:  Cinzia Severini; Cristina Zona
Journal:  Cerebellum       Date:  2006       Impact factor: 3.847

3.  NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD.

Authors:  T C Yan; A McQuillin; A Thapar; P Asherson; S P Hunt; S C Stanford; H Gurling
Journal:  J Psychopharmacol       Date:  2009-02-09       Impact factor: 4.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.